Wednesday, December 16, 2015 10:23:09 AM
Well, we got our FDA approval, we got positive update for NR2F6 going forward, Koos hired a woman with connections to be a PR name for PR and they sat on FDA approval news for 5 days, one would think, because they had a plan to try to cluster news release for impact. Maybe we get another PR this week or next on some aspect of dCellVax, but with the price reaction and trading pattern, it doesn't look like we are going anywhere fast.
This board isn't going to carry the PPS with millions of shares being released and because Koos is selling shares for .05. Until Koos raises the share price to at least near current trading price and gathers enough funds for a year, outsiders know he has to sell more shares and they are NOT going to buy even at .20 if Koos is going to issue millions of shares around .05 piecemeal to his buddies. We're being sold out because Koos doesn't care.
New president has connections, all these new board members have connections and now that the company has released news publicly, one would expect big money flowing in from those connections on a private level if not an institutional one. The fact we are dropping on the news we've been waiting for is telling unfortunately for me and all those here.
This board isn't going to carry the PPS with millions of shares being released and because Koos is selling shares for .05. Until Koos raises the share price to at least near current trading price and gathers enough funds for a year, outsiders know he has to sell more shares and they are NOT going to buy even at .20 if Koos is going to issue millions of shares around .05 piecemeal to his buddies. We're being sold out because Koos doesn't care.
New president has connections, all these new board members have connections and now that the company has released news publicly, one would expect big money flowing in from those connections on a private level if not an institutional one. The fact we are dropping on the news we've been waiting for is telling unfortunately for me and all those here.
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
